A Cohort Effect on Serum Testosterone Levels in Finnish Men.

A Perheentupa, Department of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland.
European Journal of Endocrinology (Impact Factor: 4.07). 11/2012; 168(2). DOI: 10.1530/EJE-12-0288
Source: PubMed


To investigate whether a population-level decline in serum testosterone exists in Finnish men. In comparison with other European populations, Finnish men have compared well in the studies of reproductive health (i.e. semen quality, incidence of cryptorchidism and testicular cancer); thus, we expected no significant cohort-dependent decrease in serum testosterone.

We analysed serum levels of testosterone, gonadotrophin and sex hormone binding globulin (SHBG) in 3271 men representing different ages (25-74 years) and birth cohorts within three large Finnish population surveys conducted in 1972, 1977 and 2002.

Serum testosterone levels decreased (from 25.3 nmol/l in 25- to 29-year-old men gradually to 16.9 nmol/l in 70- to 74-year-old men), whereas SHBG and gonadotrophin levels increased with increasing age. In addition, a significant secular trend in testosterone (total and free), SHBG and gonadotrophin levels was observed with lower levels in more recently born age-matched men. Serum testosterone level decreased in men aged 60-69 years from 21.9 nmol/l (men born 1913-1922) to 13.8 nmol/l (men born 1942-1951). These decreases remained significant following adjustment for BMI. An age-independent birth cohort effect existed on reproductive hormones measured in the Finnish men. In concert with the lower free testosterone levels, we observed lower gonadotrophin levels, suggesting that while there may be detrimental changes at the gonad level, the hypothalamus-pituitary-axis is not responding appropriately to this change.

The more recently born Finnish men have lower testosterone levels than their earlier born peers. This study offers no explanation for this substantial recent adverse development.

Full-text preview

Available from:
  • Source
    • "Cross-sectional studies have associated low testosterone levels with increased cardiovascular risk factors (diabetes mellitus, the metabolic syndrome, abnormal lipid profile) and increased cardiovascular risk in men.2–5 This is particularly important given the progressive population-level decline in serum testosterone concentrations in men from developed countries6–8 which has resulted in a dramatic increase in the use of androgen replacement therapy (ART). Indeed, there has been a 10-fold increase in prescribed ART in the USA9 and nearly a 3-fold increase in the UK10 in the past decade. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aims Low androgen levels have been linked with an increased risk of cardiovascular disease in men. Previous studies have suggested that androgens directly inhibit atherosclerotic lesion formation although the underlying mechanisms for this remain unclear. This study addressed the hypothesis that endogenous androgens inhibit arterial remodelling by a direct action on the androgen receptor (AR) in the vascular wall. Methods and results We studied a series of novel mouse lines with cell-specific deletion of the AR in either the endothelium or in smooth muscle cells or both cell types. Findings were compared with a model of global androgen deficiency in wild-type mice (castrated). We characterized the cardiovascular phenotype, vascular pharmacology and histology, and assessed neointimal lesion formation following vascular injury to the femoral artery. Cell-specific AR deletion did not alter body weight, circulating testosterone levels or seminal vesicle weight, but caused limited alterations in arterial contractility and blood pressure. Neointimal lesion formation was unaltered by selective deletion of AR from the vascular endothelium, smooth muscle, or both cell types. Castration in wild-type mice increased neointimal lesion volume (Sham vs. Castration: 2.4 × 107 ± 4.5 × 106 vs. 3.9 × 107 ± 4.9 × 106 µm3, P = 0.04, n = 9–10). Conclusion Vascular cell-specific AR deletion had no effect on neointimal lesion formation, while low systemic androgen levels adversely affect neointimal lesion size. These findings suggest that the cardio-protective effects of androgens are mediated either by AR outside the vasculature or by AR-independent mechanisms.
    Full-text · Article · Jun 2014 · Cardiovascular Research
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Kartagener's syndrome (KS) is characterized by the classic triad of chronic sinusitis, bronchiectasis and situs inversus. This is caused by dynein arm defects in axonemal microtubules in ciliary and flagellar structures. Male patients are invariably infertile because of the immotility of spermatozoa. We report a healthy birth that was achieved by intracytoplasmic sperm injection (ICSI) using ejaculated spermatozoa from a patient with KS. Case report: The wife of the patient was a 33-year-old woman with infertility of one-year duration.Her diagnostic infertility work-ups were normal. Her husband was 33 years old. He had normal secondary sex characteristics and both testicular volumes were normal. His serum FSH, LH, testosterone and prolactin levels were all within normal limits. He had dextrocardia and dysosmia as well as a history of chronic bronchitis and sinusitis, the classic triad disorders of KS, and was therefore diagnosed with KS. Several semen analyses showed sperm concentration of 77-87 × 10 6 /ml and ejaculated volume of 3.5-4.0 ml. However, only 2-28 motile spermatozoa were observed in the whole field with a Makler Counting Chamber. After eosin staining, 30% of the sperm were viable with unremarkable morphology. Transmission electron microscopy (TEM) of the sperm tail showed the absence of both inner and outer dynein arms. After counseling for this condition and suitability for ICSI, the couple proceeded with ICSI using ejaculated spermatozoa. In August 2005, after ovarian stimulation by a long protocol using GnRHa / hMG, twenty-one oocytes were obtained, and 18 metaphase II oocytes were retrieved. Fresh semen samples were obtained after masturbation. The sperm concentration was 57.2 × 10 6 /ml and the volume was 3.5 ml. Total motility was 0.3%, and no spermatozoa showed straight progressive motility. After swim-up preparation, we observed a few motile spermatozoa that appeared morphologically normal, and these motile spermatozoa were selected for ICSI. Thirteen oocytes were fertilized. All embryos were cryopreserved in the cleavage stage to prevent development of ovarian hyperstimulation syndrome. In October 2005, two--step embryo transfer was performed in the hormone replacement (HR) cycle. A twin pregnancy was achieved, one resulting in missed abortion but the other being uneventful. A healthy female infant was delivered in June 2006 at a gestation age of 37 weeks and weighing 2675 g. In April 2008, the couple was referred to our clinic for a second pregnancy. Four cycles of single blastocyst transfer using a cryopreserved-thawed blastocyst were repeatedly performed. Pregnancy tests were positive in three cycles, but all of the three pregnancies resulted in chemical abortion. In January 2009, after using an ovarian stimulation protocol similar to that used in the first cycle, five metaphase II oocytes were retrieved. Sperm concentration and total motility were 68.1 × 10 6 /ml and 0.1%, respectively, and a few progressive motile sperm were observed. The intracytoplasmic morphologically selected sperm injection (IMSI) procedure was performed with the progressive motile sperm. All oocytes were fertilized. One embryo was cryopreserved in the cleavage stage and the other four embryos were cultured for three more days, but no blastocyst was obtained. In March 2009, cryopreserved-thawed embryo transfer was performed in the HR cycle, but pregnancy was not achieved. Conclusion: This case report demonstrates that successful pregnancy after ICSI in couples with Kartagener's syndrome is possible with ejaculated spermatozoa. Our results suggest that even for KS patients, if motile sperm are observed, a fertilization rate comparable to that with ICSI of the other male factor can be expected. KS is a heterogeneous group of disorders with similar clinical presentations, and treatment should be individualized depending on sperm motility.
    Full-text · Article · Jun 2010 · Human Reproduction
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The testosterone of men in industrial societies peaks in their twenties and tends to decline with increasing age. Apart from this individual-level decline, there have been reports of a secular (age-independent population-level) decline in testosterone among American and Scandinavian men during the past few decades, possibly an indication of declining male reproductive health. It has been suggested that both declines in testosterone (individual-level and population-level) are due to increasing male obesity because men in industrial society tend to add body fat as they age, and overall rates of obesity are increasing. Using an unusually large and lengthy longitudinal dataset (991 US Air Force veterans examined in six cycles over 20 years), we investigate the relationship of obesity to individual and population-level declines in testosterone. Over twenty years of study, longitudinal decline in mean testosterone was at least twice what would be expected from cross-sectional estimates of the aging decline. Men who put on weight intensified their testosterone decline, some greatly so, but even among those who held their weight constant or lost weight during the study, mean testosterone declined 117 ng/dl (19%) over 20 years. We have not identified the reason for secular decline in testosterone, but we exclude increasing obesity as a sufficient or primary explanation, and we deny the supposition that men who avoid excessive weight will maintain their youthful levels of testosterone.
    Full-text · Article · Oct 2013 · PLoS ONE
Show more